Indefinite Delivery Contract SPE2DR25D3944

The federal contract IDV award SPE2DR25D3944 is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical and medical supply products to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The IDC serves as a primary vehicle for DLA to efficiently procure essential medical commodities, enabling the provision of healthcare to military personnel, veterans, and other federal beneficiaries. The contract has a 30-month base period with three 30-month option periods, for a total period of performance through December 2026.

The original solicitation, DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), is an unrestricted, fully competitive acquisition that aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, the U.S. Coast Guard, and other government agencies. The solicitation is expected to be issued in March 2024 and will remain open for 45 days, with awards made on a regional basis (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) to at least three different contractors as primary and backup suppliers.